Showing results (951-960 of 5,345) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|December 24, 2019
The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumorsBeijiao Qin, Wenyan Xu, Yanfang Li
Japanese Journal of Clinical Oncology|March 27, 2020
Combined sleeve lobectomy for centrally located primary lung cancer and lung cancer with hilar lymph node metastasisTakuma Tsukioka, Nobuhiro Izumi, Hiroaki Komatsu, et al.
Japanese Journal of Clinical Oncology|March 27, 2020
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancerEriko Miyawaki, Haruyasu Murakami, Keita Mori, et al.
Japanese Journal of Clinical Oncology|October 22, 2020
Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter studyKeiichi Ito, Shuji Mikami, Naoto Kuroda, et al.
Japanese Journal of Clinical Oncology|October 22, 2020
Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapyMasanori Someya, Takaaki Tsuchiya, Yuki Fukushima, et al.
Japanese Journal of Clinical Oncology|October 13, 2020
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancerShinobu Hosokawa, Eiki Ichihara, Akihiro Bessho, et al.
Japanese Journal of Clinical Oncology|October 6, 2020
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studiesHideo Saka, Makoto Nishio, Toyoaki Hida, et al.
Japanese Journal of Clinical Oncology|December 28, 2018
Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD)Hideaki Kitahara, Yoshitaka Honma, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|October 31, 2019
Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance studyNagane Motoo, Yasuko Hayashi, Ayaka Shimizu, et al.
Japanese Journal of Clinical Oncology|October 31, 2019
Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm studyHideki Enokida, Yasutoshi Yamada, Shuichi Tatarano, et al.
Pageof 535